This meta-analysis explored the safety and effectiveness of mucolytics as an add-on
treatment for chronic obstructive pulmonary disease (COPD) exacerbations. Based on a pre …

Introduction: Chronic obstructive pulmonary disease (COPD) is more prevalent in people
with HIV (PWH) than in the general population and leads to an increased burden of …

Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …

Rationale: Many decisions to admit patients to the ICU are not grounded in evidence
regarding who benefits from such triage, straining ICU capacity and limiting its cost …

Introduction: Muscle impairments are prevalent in COPD and have adverse clinical
implications in terms of physical performance capacity, disease burden, quality of life and …

Background: Pulmonary rehabilitation is a crucial part of the nonpharmacological treatment
of stable chronic obstructive pulmonary disease (COPD), but management remains …

This meta-analysis compares the efficacy and safety of inhaled versus systemic
corticosteroids for COPD exacerbations. Following a pre-registered protocol, we appraised …

Aim To compare prednisone and placebo for the treatment of outpatients treated for acute
exacerbations of chronic obstructive pulmonary disease (COPD) in a primary care setting …

This meta-analysis compares the efficacy and safety of inhaled versus systemic
corticosteroids for COPD exacerbations. Following a pre-registered protocol, we appraised …

Pharmacologic Management of COPD Exacerbations: A Clinical Practice Guideline from the
AAFP | AAFP Advertisement search close brand logo JAMES J. STEVERMER, MD, MSPH …